We are live on ! Find out more
KLWA

Kelly Lawrence W & Associates Portfolio holdings

AUM $360M
1-Year Est. Return 16.9%
This Fund
S&P 500
This Quarter Est. Return
+7.52%
1 Year Est. Return
+16.9%
3 Year Est. Return
+58.93%
5 Year Est. Return
+78.96%
10 Year Est. Return
+418.66%
AUM
$586M
AUM Growth
+$32.3M
Cap. Flow
-$6.21M
Cap. Flow %
-1.06%
Top 10 Hldgs %
40.74%
Holding
135
New
7
Increased
13
Reduced
47
Closed
1

Top Buys

Rank Stock Value
1
SLB icon
SLB Ltd
SLB
+$1.97M
2
FTV icon
Fortive
FTV
+$1.18M
3
DOW icon
Dow Inc
DOW
+$424K
4
BGS icon
B&G Foods
BGS
+$263K
5
CTVA icon
Corteva
CTVA
+$197K

Top Sells

Rank Stock Value
1
AMD icon
Advanced Micro Devices
AMD
+$4.5M
2
AGN
Allergan plc
AGN
+$1.59M
3
AAPL icon
Apple
AAPL
+$399K
4
DD icon
DuPont de Nemours
DD
+$375K
5
PYPL icon
PayPal
PYPL
+$361K

Sector Composition

Rank Sector Weight
1 Technology 26.42%
2 Financials 17.17%
3 Healthcare 16.87%
4 Consumer Discretionary 14.36%
5 Consumer Staples 7.76%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
REZI icon
126
Resideo Technologies
REZI
$3.69B
$2K ﹤0.01%
98
GTX icon
127
Garrett Motion
GTX
$5.43B
$1K ﹤0.01%
59
AGN
128
DELISTED
Allergan plc
AGN
-10,873
Closed -$1.59M

Similar funds

Kelly Lawrence W & Associates's Q2 2019 Portfolio in Review

As of Q2 2019, Kelly Lawrence W & Associates held 135 positions worth $586M, up 5.8% from $554M the previous quarter. Its ten largest holdings account for 41% of the portfolio.

Kelly Lawrence W & Associates's Q2 2019 filing shows 7 new, 13 increased, 47 reduced and 1 closed positions. Its largest new stake was Dow Inc: 8,029 shares worth $396K. The largest sale was Advanced Micro Devices, an estimated $4.5M.

By sector, the portfolio is most concentrated in Technology at 26% of assets, down from 27% a quarter earlier, followed by Financials and Healthcare.

  • Kelly Lawrence W & Associates's largest Q2 2019 buy was Dow Inc: 8,029 shares worth $396K.
  • Kelly Lawrence W & Associates added most to SLB Ltd in Q2 2019, an estimated $1.97M increase.
  • Kelly Lawrence W & Associates's biggest Q2 2019 reduction was Advanced Micro Devices, cutting an estimated $4.5M.
  • Kelly Lawrence W & Associates fully exited Allergan plc in Q2 2019, selling an estimated $1.59M.
  • Kelly Lawrence W & Associates's ten largest holdings make up 41% of its $586M portfolio in Q2 2019.
  • Kelly Lawrence W & Associates opened 7 new positions and closed 1 in Q2 2019.
  • Kelly Lawrence W & Associates's portfolio value rose 5.8% quarter-over-quarter to $586M.

Based on Kelly Lawrence W & Associates's 13F filing for Q2 2019, filed 14 Aug 2019.